Search Follow us

Latest research


Domatinostat R&D ramp-up in H218

Update | Pharmaceutical & healthcare | 17/08/2018

During the Q218 results call, 4SC management announced that with current funds, it plans to initiate some of its additional domatinostat trials including…

Sunesis Pharmaceuticals

Interim readout coming up

Update | Pharmaceutical & healthcare | 17/08/2018

Sunesis has reported Q2 earnings and provided an update on enrolment in its ongoing dose escalation study of vecabrutinib. It continues to enrol the 50mg…

Hutchison China MediTech

Establishing a global operational presence

Update | Pharmaceutical & healthcare | 17/08/2018

Highlights from Hutchison China MediTech’s (HCM) H118 results relate to the substantial pipeline-related newsflow expected in 2018/19, the recent…

7digital Group

Ready to rock ’n' roll

Update | Technology | 16/08/2018

7digtal has now reported its FY17 results, which show a strong uplift in revenues, reflecting the 24-7 acquisition, and a greatly reduced EBITDA loss.…

Sarine Technologies

Cost reductions driving profitability

Update | General Industrials | 16/08/2018

Sarine’s prudent cost management in Q218 translated into a 12.4% y-o-y increase in EBIT to US$4.7m, despite the lack of top-line growth. The company…